Global Conference 2013
Executive Chairman, Kite Pharma, Inc.; Director, UCLA Institute of Urologic Oncology
Arie Belldegrun is founder and executive chairman of Kite Pharma Inc., director of the Institute of Urologic Oncology at the University of California, Los Angeles, and professor and chair of urologic oncology at the David Geffen School of Medicine at UCLA. Belldegrun was the founding chairman of Agensys Inc. and co-founder of Cougar Biotechnology. He has served as chairman of the molecular and biological technology committee of the American Urological Association and as a member of the Governor's Council on Bioscience for California. He is on the board of Teva Pharmaceutical Industries Ltd. and is chairman of Arno Therapeutics Inc. and TheraCoat Ltd. Belldegrun received his medical degree at the Hebrew University of Hadassah Medical School. He completed his residency in urologic surgery at Harvard Medical School and his surgical oncology fellowship at the National Cancer Institute in the National Institutes of Health.